Related Experiment Videos
Anti-erythrocyte autoimmunization in hydatid disease
G Girelli1, A Teggi, M P Perrone
1Department of Experimental Medicine, La Sapienza University of Rome, Italy.
International Journal of Clinical & Laboratory Research
|January 1, 1993
Summary
Hydatid disease can trigger autoimmune hemolytic anemia by causing the body to produce antibodies against its own red blood cells. Treatment for the parasitic infection may resolve this autoimmune condition.
Area of Science:
- Immunology
- Parasitology
- Hematology
Background:
- Hydatid disease, a parasitic infection, can lead to complex immunological complications.
- Autoimmune hemolytic anemia (AIHA) is characterized by autoantibodies targeting red blood cells.
Observation:
- A patient with hydatid disease and AIHA (IgM cold agglutinin, anti-I specificity) showed reduced hemolysis and autoantibodies after mebendazole treatment.
- Parasite cysts diminished in size concurrently with the resolution of autoantibodies.
- Further investigation revealed IgM cold autoantibodies in another hydatid disease patient and complement system activation (C3 fragments) on erythrocytes in six patients.
Findings:
- Parasitic antigens in hydatid disease may induce cross-reactive antibodies against host red blood cells.
- The complement system is chronically activated in some patients with hydatid disease.
- Resolution of parasitic infection correlates with the disappearance of red cell autoantibodies.
Implications:
- This suggests a potential mechanism for parasitic infections triggering autoimmune responses.
- Targeting parasitic antigens could be a therapeutic strategy for related autoimmune conditions.
- Early diagnosis and treatment of hydatid disease may prevent or reverse associated hematological complications.